Antonio Marra: Our review on current use and future development of PARP inhibitors in breast cancer just out in JAMA Oncology

Antonio Marra, Medical Oncologist at the European Institute of Oncology, on LinkedIn:

“Excited to see our review on current use and future development of PARP inhibitors in breast cancer just out in JAMA Oncology

Many steps have been made in the last 20 yrs, a vast amount is left waiting to be explored

• Patient population who may benefit from PARPi
• New drugs (e.g., PARP1-selective) to reduce toxicity
• Novel combos with IO and ADCs

Amazing collaboration with many Italian and American colleagues and friends Stefania Morganti, Carmen Criscitiello, Giuseppe Curigliano, Carmine De Angelis, Giampaolo Bianchini, Luca Licata, Angela Esposito, IEO Istituto Europeo di Oncologia, Dana-Farber Cancer Institute.”

Read further.
Source: Antonio Marra/LinkedIn